Evidence map›Paper›PMID 21961050›Full record

ArticleOxidative medicine and cellular longevity2011

Effect of novel marine nutraceuticals on IL-1α-mediated TNF-α release from UVB-irradiated human melanocyte-derived cells.

Visalini Muthusamy, Lynn D Hodges, Theodore A Macrides, Glen M Boyle, Terrence J Piva

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Anti-Photodamage Effect ofInternational journal of molecular sciences · 2024
    Article
  2. Marine Compounds for Melanoma Treatment and Prevention.International journal of molecular sciences · 2022
    Review
  3. Review
  4. Article
  5. Article
  6. Cellular Mechanisms of Oxidative Stress and Action in Melanoma.Oxidative medicine and cellular longevity · 2015
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Visalini MuthusamySchool of Medical Sciences, RMIT University, P.O. Box 71, Bundoora, VIC 3083, Australia. visalini.muthusamy@rmit.edu.au
Lynn D Hodges
Theodore A Macrides
Glen M Boyle
Terrence J Piva
RMIT University · AUQIMR Berghofer Medical Research Institute · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

UV-induced inflammation and reactive oxygen species formation are involved in the development of melanoma. Natural products like 5β-scymnol and CO(2)-supercritical fluid extract (CO(2)-SFE) of mussel oil contain anti-inflammatory and antioxidant properties that may aid in reducing the deleterious effects of UV radiation. Therefore, their effect on the release of the proinflammatory cytokine, tumour necrosis factor-α (TNF-α), from UVB-irradiated human melanocytic cells was examined. Human epidermal melanocytes (HEM) and MM96L melanoma cells were exposed to UVB radiation and IL-1α. Cell viability and TNF-α levels were determined 24 hours after-irradiation while p38 mitogen-activated protein kinase (MAPK) activation was observed at 15 min after-irradiation. When α-tocopherol, CO(2)-SFE mussel oil, and 5β-scymnol were added to the UVB-irradiated HEM cells treated with IL-1α, TNF-α levels fell by 53%, 65%, and 76%, respectively, while no inhibition was evident in MM96L cells. This effect was not due to inhibition of the intracellular p38 MAPK signalling pathway. These compounds may be useful in preventing inflammation-induced damage to normal melanocytes.

Indexed as

Dietary SupplementsUltraviolet RaysAnimalsAntioxidantsBiphenyl CompoundsCells, CulturedCell SurvivalHumansHydrogen PeroxideInflammationInterleukin-1alphaIronMelanocytesMelanoma, ExperimentalMicep38 Mitogen-Activated Protein Kinases1,1-diphenyl-2-picrylhydrazylAntioxidantsBiphenyl CompoundsFenton's reagentHydrogen PeroxideInterleukin-1alphaIronp38 Mitogen-Activated Protein KinasesPicratesReactive Oxygen SpeciesTumor Necrosis Factor-alpha

Identifiers

PMID21961050
PMCPMC3179886
OpenAlexW2027434198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.